Efficacy Is Impacted by
Celina García-García, M. Rivas, Y. Ibrahim et al.
· 0 citations
We have 2 of 549 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
It is argued that achieving the potential of AI in oncology clinical trials will require rigorous prospective validation, harmonized regulatory standards, and coordination among clinicians, trialists, regulators, industry and patients.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.